T1	CHEM 80 90	evolocumab
#1	AnnotatorNotes T1	C3529352; evolocumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T2	PROC 143 150	placebo
#2	AnnotatorNotes T2	C0032042; Placebos; Therapeutic or Preventive Procedure
T3	DISO 168 193	enfermedad cardiovascular
#3	AnnotatorNotes T3	C0007222; Cardiovascular Diseases; Disease or Syndrome
T4	PROC 209 220	tratamiento
#4	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	PROC 258 317	Estudio multicéntrico, doble ciego y controlado con placebo
T6	CHEM 344 354	evolocumab
#5	AnnotatorNotes T6	C3529352; evolocumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	DISO 396 421	enfermedad cardiovascular
#6	AnnotatorNotes T7	C0007222; Cardiovascular Diseases; Disease or Syndrome
T8	PROC 458 484	tratamiento hipolipemiante
T9	PROC 738 762	Consentimiento informado
#7	AnnotatorNotes T9	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T10	DISO 951 954	DCL
T11	CHEM 582 592	Evolocumab
#8	AnnotatorNotes T11	C3529352; evolocumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T12	CHEM 649 656	lípidos
#9	AnnotatorNotes T12	C0023779; Lipids; Organic Chemical
T13	ANAT 663 669	sangre
#10	AnnotatorNotes T13	C0005767; Blood; Body Substance
T14	DISO 696 708	Dislipidemia
#11	AnnotatorNotes T14	C0242339; Dyslipidemias; Disease or Syndrome
T15	PROC 874 885	Diagnóstico
#12	AnnotatorNotes T15	C0011900; Diagnosis; Diagnostic Procedure
T16	DISO 914 922	demencia
#13	AnnotatorNotes T16	C0497327; Dementia; Mental or Behavioral Dysfunction
T17	DISO 925 949	deterioro cognitivo leve
T18	DISO 970 979	trastorno
#14	AnnotatorNotes T18	C0012634; Disease; Disease or Syndrome
T19	DISO 1009 1043	trastornos mentales o neurológicos
T20	ANAT 179 193	cardiovascular
#15	AnnotatorNotes T20	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T21	CHEM 225 234	estatinas
#16	AnnotatorNotes T21	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T22	ANAT 407 421	cardiovascular
#17	AnnotatorNotes T22	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T23	CHEM 470 484	hipolipemiante
#18	AnnotatorNotes T23	C0086440; Hypolipidemic Agents; Pharmacologic Substance
T24	CHEM 497 506	estatinas
#19	AnnotatorNotes T24	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T25	DISO 625 669	Cantidades anormales de lípidos en la sangre
T26	Date 13 17	2014
T27	LIVB 154 163	pacientes
#20	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	PHYS 361 378	función cognitiva
#21	AnnotatorNotes T28	C0009240; Cognition; Mental Process
T29	LIVB 382 391	pacientes
#22	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	LIVB 524 531	sujetos
#23	AnnotatorNotes T30	C0681850; Study Subject; Group
T31	Date 886 892	actual
T32	Date 895 901	pasado
T33	LIVB 1079 1091	investigador
#24	AnnotatorNotes T33	C0035173; Research Personnel; Professional or Occupational Group
T36	LIVB 1201 1207	sujeto
#25	AnnotatorNotes T36	C0681850; Study Subject; Group
T37	PHYS 935 944	cognitivo
#26	AnnotatorNotes T37	C0009240; Cognition; Mental Process
T38	PHYS 1020 1028	mentales
#27	AnnotatorNotes T38	C0229992; Psyche structure; Mental Process
T34	PROC 799 811	Aleatorizado
#28	AnnotatorNotes T34	C0034656; Randomization; Research Activity
T35	PHYS 100 123	capacidad para aprender
#29	AnnotatorNotes T35	C0233832; Learning ability; Mental Process
A1	Status T16 History_of
A2	Status T17 History_of
A3	Status T10 History_of
#30	AnnotatorNotes T5	C1096776; Multicenter Study; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#31	AnnotatorNotes T8	C0585943; Lipid-lowering therapy; Therapeutic or Preventive Procedure 
#32	AnnotatorNotes T17	C1270972; Mild cognitive disorder; Mental or Behavioral Dysfunction 
#33	AnnotatorNotes T10	C1270972; Mild cognitive disorder; Mental or Behavioral Dysfunction 
#34	AnnotatorNotes T19	C0027765; nervous system disorder; Disease or Syndrome + C0004936; Mental disorders; Mental or Behavioral Dysfunction
#35	AnnotatorNotes T31	C0521116; Current (present time); Temporal Concept 
#36	AnnotatorNotes T32	C1444637; In the past; Temporal Concept
T39	Observation 70 76	efecto
#37	AnnotatorNotes T39	C1518681; Outcome of Therapy; Finding (?)
R1	Causes Arg1:T1 Arg2:T39	
R2	Causes Arg1:T2 Arg2:T39	
R3	Experiences Arg1:T27 Arg2:T39	
R4	Experiences Arg1:T27 Arg2:T1	
R5	Experiences Arg1:T27 Arg2:T35	
R6	Experiences Arg1:T27 Arg2:T2	
R7	Experiences Arg1:T27 Arg2:T3	
R8	Location_of Arg1:T20 Arg2:T3	
R9	Used_for Arg1:T21 Arg2:T4	
R10	Experiences Arg1:T27 Arg2:T4	
R11	Overlap Arg1:T1 Arg2:T4	
R12	Overlap Arg1:T2 Arg2:T4	
T40	Observation 334 340	efecto
#38	AnnotatorNotes T40	C1518681; Outcome of Therapy; Finding (?)
R13	Causes Arg1:T6 Arg2:T40	
R14	Experiences Arg1:T29 Arg2:T28	
R15	Experiences Arg1:T29 Arg2:T6	
R16	Experiences Arg1:T29 Arg2:T40	
R17	Experiences Arg1:T29 Arg2:T7	
R18	Location_of Arg1:T22 Arg2:T7	
R19	Experiences Arg1:T29 Arg2:T8	
R20	Used_for Arg1:T24 Arg2:T8	
R21	Used_for Arg1:T23 Arg2:T8	
R22	Experiences Arg1:T29 Arg2:T11	
R23	Experiences Arg1:T30 Arg2:T11	
R24	Experiences Arg1:T30 Arg2:T8	
R25	Experiences Arg1:T30 Arg2:T7	
R26	Experiences Arg1:T30 Arg2:T28	
R27	Experiences Arg1:T30 Arg2:T6	
R28	Experiences Arg1:T30 Arg2:T40	
R29	Location_of Arg1:T13 Arg2:T25	
T41	PROC 779 786	estudio
#39	AnnotatorNotes T41	C0008976; Clinical Trials; Research Activity
R30	Before Arg1:T9 Arg2:T41	
T42	PROC 818 825	estudio
#40	AnnotatorNotes T42	C0008976; Clinical Trials; Research Activity
R31	Overlap Arg1:T34 Arg2:T42	
#41	AnnotatorNotes T25	C0549634; Lipids abnormal; Finding
R32	Overlap Arg1:T15 Arg2:T31	
R33	Overlap Arg1:T15 Arg2:T32	
R36	Overlap Arg1:T16 Arg2:T31	
R37	Overlap Arg1:T16 Arg2:T32	
R38	Overlap Arg1:T17 Arg2:T31	
R39	Overlap Arg1:T17 Arg2:T32	
R40	Overlap Arg1:T10 Arg2:T32	
R41	Overlap Arg1:T10 Arg2:T31	
T43	Quantifier_or_Qualifier 1044 1058	significativos
#42	AnnotatorNotes T43	C1546944; Event Seriousness - Significant; Qualitative Concept
R43	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T43	
T44	Spec_cue 1140 1146	puedan
T45	CONC 1147 1157	interferir
A4	Assertion T45 Speculated
#43	AnnotatorNotes T45	C0521102; Interferes with; Functional Concept
R44	Speculation Arg1:T44 Arg2:T45	
T46	Observation 1183 1207	participación del sujeto
A5	Assertion T46 Speculated
#44	AnnotatorNotes T46	C1278516; Patient participation status; Finding (?)
R45	Speculation Arg1:T44 Arg2:T46	
T47	Spec_cue 1093 1099	puedan
R47	Experiences Arg1:T36 Arg2:T18	
R48	Experiences Arg1:T36 Arg2:T19	
T48	Observation 1100 1124	confundir los resultados
A6	Assertion T48 Speculated
R49	Speculation Arg1:T47 Arg2:T48	
R50	Before Arg1:T18 Arg2:T48	
R51	Before Arg1:T19 Arg2:T48	
A7	Experiencer T27 Patient
A8	Experiencer T29 Patient
A9	Experiencer T30 Patient
A10	Experiencer T33 Other
A11	Experiencer T36 Patient
